Seres Therapeutics
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell MCRB and other ETFs, options, and stocks.About MCRB
Seres Therapeutics, Inc. engages in the development of biological drugs through microbiome therapeutics platform. Its product pipeline includes SER-109, SER-287, SER-301, and SER-401.
CEORichard N. Kender
CEORichard N. Kender
Employees66
Employees66
HeadquartersCambridge, Massachusetts
HeadquartersCambridge, Massachusetts
Founded2010
Founded2010
Employees66
Employees66
MCRB Key Statistics
Market cap87.71M
Market cap87.71M
Price-Earnings ratio12.89
Price-Earnings ratio12.89
Dividend yield—
Dividend yield—
Average volume54.15K
Average volume54.15K
High today$9.47
High today$9.47
Low today$8.38
Low today$8.38
Open price$8.38
Open price$8.38
Volume46.07K
Volume46.07K
52 Week high$29.98
52 Week high$29.98
52 Week low$6.53
52 Week low$6.53
Stock Snapshot
With a market cap of 87.71M, Seres Therapeutics(MCRB) trades at $9.14. The stock has a price-to-earnings ratio of 12.89.
As of 2026-03-26, Seres Therapeutics(MCRB) stock has fluctuated between $8.38 and $9.47. The current price stands at $9.14, placing the stock +9.1% above today's low and -3.5% off the high.
Seres Therapeutics(MCRB) shares are trading with a volume of 46.07K, against a daily average of 54.15K.
During the past year, Seres Therapeutics(MCRB) stock moved between $6.53 at its lowest and $29.98 at its peak.
During the past year, Seres Therapeutics(MCRB) stock moved between $6.53 at its lowest and $29.98 at its peak.
People also own
Based on the portfolios of people who own MCRB. This list is generated using Robinhood data, and it’s not a recommendation.